{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:52:18Z","timestamp":1762876338312,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Tianjin City in China","award":["18JCZDJC32600"],"award-info":[{"award-number":["18JCZDJC32600"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Early diagnosis is essential for improving the prognosis and survival of patients with hepatocellular carcinoma (HCC). This study aims to explore the clinical value of lipoprotein subfractions in the diagnosis of hepatitis B virus (HBV)-related HCC. Lipoprotein subfractions were detected by 1H-NMR spectroscopy, and the pattern-recognition method and binary logistic regression were performed to classify distinct serum profiles and construct prediction models for HCC diagnosis. Differentially expressed proteins associated with lipid metabolism were detected by LC-MS\/MS, and the potential prognostic significance of the mRNA expression was evaluated by Kaplan\u2013Meier survival analysis. The diagnostic panel constructed from the serum particle number of very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL-1~LDL-6) achieved higher accuracy for the diagnosis of HBV-related HCC and HBV-related benign liver disease (LD) than that constructed from serum alpha-fetoprotein (AFP) alone in the training set (AUC: 0.850 vs. AUC: 0.831) and validation set (AUC: 0.926 vs. AUC: 0.833). Furthermore, the panel achieved good diagnostic performance in distinguishing AFP-negative HCC from AFP-negative LD (AUC: 0.773). We also found that lipoprotein lipase (LPL) transcript levels showed a significant increase in cancerous tissue and that high expression was significantly positively correlated with the poor prognosis of patients. Our research provides new insight for the development of diagnostic biomarkers for HCC, and abnormal lipid metabolism and LPL-mediated abnormal serum lipoprotein metabolism may be important factors in promoting HCC development.<\/jats:p>","DOI":"10.3390\/jpm11111143","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T09:11:32Z","timestamp":1636017092000},"page":"1143","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0308-8525","authenticated-orcid":false,"given":"Duo","family":"Zuo","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2821-900X","authenticated-orcid":false,"given":"Haohua","family":"An","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-6371","authenticated-orcid":false,"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2318-7253","authenticated-orcid":false,"given":"Jiawei","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-6003","authenticated-orcid":false,"given":"Li","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11427-017-9259-9","article-title":"42,573 cases of hepatectomy in China: A multicenter retrospective investigation","volume":"61","author":"Zhang","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-Based Diagnosis, Staging, and Treatment of Patients with Hepatocellular Carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/gut.2008.149062","article-title":"Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: A systematic review and meta-analysis","volume":"57","author":"Silva","year":"2008","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cld.2015.01.005","article-title":"Elevated Alpha-Fetoprotein","volume":"19","author":"Wong","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: Beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","article-title":"The future of NMR-based metabolomics","volume":"43","author":"Markley","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrendo.2016.98","article-title":"Lipidomics for studying metabolism","volume":"12","author":"Han","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.tibs.2016.08.010","article-title":"Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences","volume":"41","author":"Yang","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","article-title":"Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial","volume":"90","author":"Holmes","year":"2018","journal-title":"Anal. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-511X-5-4","article-title":"Influence of liver cancer on lipid and lipoprotein metabolism","volume":"5","author":"Jiang","year":"2006","journal-title":"Lipids Health Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10620-017-4862-x","article-title":"Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance","volume":"63","author":"Privitera","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/ac402571z","article-title":"A Systematic Approach to Obtain Validated Partial Least Square Models for Predicting Lipoprotein Subclasses from Serum NMR Spectra","volume":"86","author":"Mihaleva","year":"2013","journal-title":"Anal. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study","volume":"49","author":"Stroes","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/pr500061n","article-title":"NMR-Based Lipidomic Analysis of Blood Lipoproteins Differentiates the Progression of Coronary Heart Disease","volume":"13","author":"Kostara","year":"2014","journal-title":"J. Proteome Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Casadei-Gardini, A., Del Coco, L., Marisi, G., Conti, F., Rovesti, G., Ulivi, P., Canale, M., Frassineti, G.L., Foschi, F.G., and Longo, S. (2020). 1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages. Cancers, 12.","DOI":"10.3390\/cancers12010241"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Fages, A., Duarte-Salles, T., Stepien, M., Ferrari, P., Fedirko, V., Pontoizeau, C., Trichopoulou, A., Aleksandrova, K., Tj\u00f8nneland, A., and Olsen, A. (2015). Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med., 13.","DOI":"10.1186\/s12916-015-0462-9"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1158\/1078-0432.CCR-12-1099","article-title":"Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis","volume":"18","author":"Nahon","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3748\/wjg.v22.i16.4191","article-title":"Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study","volume":"22","author":"Cox","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e3916","DOI":"10.1002\/nbm.3916","article-title":"Nuclear magnetic resonance (NMR)-based metabolomics for cancer research","volume":"32","author":"Ranjan","year":"2018","journal-title":"NMR Biomed."},{"key":"ref_23","first-page":"1","article-title":"Triglyceride Metabolism in the Liver","volume":"8","author":"Cohen","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1515\/cclm-2013-0358","article-title":"Recent advances in physiological lipoprotein metabolism","volume":"52","author":"Ramasamy","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOL.0000000000000569","article-title":"Lipoprotein metabolism in liver diseases","volume":"30","author":"Sandhu","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.plipres.2013.08.005","article-title":"Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids","volume":"52","author":"Zaidi","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: Cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sangineto, M., Villani, R., Cavallone, F., Romano, A., Loizzi, D., and Serviddio, G. (2020). Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12061419"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_31","first-page":"1390","article-title":"Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases (Review)","volume":"16","author":"Tang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41389-020-0226-z","article-title":"ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK\/FBW7\/c-Myc axis","volume":"9","author":"Chen","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-nutr-071714-034338","article-title":"New Insights into the Regulation of Chylomicron Production","volume":"35","author":"Dash","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kumari, A., Kristensen, K.K., Ploug, M., and Winther, A.L.-M. (2021). The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070782"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2019.05.023","article-title":"GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism","volume":"30","author":"Young","year":"2019","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3389\/fcell.2021.702508","article-title":"GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL Activity","volume":"9","author":"Kristensen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/liv.13183","article-title":"Bothde novosynthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells","volume":"37","author":"Cao","year":"2016","journal-title":"Liver Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41418-019-0453-z","article-title":"Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake","volume":"27","author":"Wu","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"166228","DOI":"10.1016\/j.bbadis.2021.166228","article-title":"Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis","volume":"1867","author":"Manupati","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2016.11.033","article-title":"VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis","volume":"388","author":"Lu","year":"2016","journal-title":"Cancer Lett."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/11\/1143\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:25:35Z","timestamp":1760167535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/11\/1143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["jpm11111143"],"URL":"https:\/\/doi.org\/10.3390\/jpm11111143","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2021,11,4]]}}}